Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Flagship Labs is the institutional innovation foundry of Flagship Pioneering, dedicated to systematically conceiving, creating, and resourcing first-in-category bioplatform companies. It operates through a unique hypothesis-driven process where internal teams of scientist-entrepreneurs explore 'white spaces' in biology to develop 'ProtoCos' (prototype companies). These ventures, often designated with 'FL' numbers during their stealth phase, evolve into independent entities such as Moderna, Generate Biomedicines, and Tessera Therapeutics. Flagship Labs focuses on transformative technologies in human health and sustainability, leveraging an ecosystem of over 40 active companies. Through its Pioneering Medicines initiative, the unit also collaborates with major pharmaceutical partners like Pfizer and Novo Nordisk to advance a pipeline of novel therapeutic assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Flagship Labs.